oleanolic acid has been researched along with 9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)- in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Feng, Y; Gu, L; Guo, J; Jiang, H; Li, Y; Liao, S; Ma, L; Sun, M; Wang, H; Wen, H; Yu, X; Zeng, B; Zhou, Y | 1 |
1 other study(ies) available for oleanolic acid and 9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)-
| Article | Year |
|---|---|
3-O-(Z)-coumaroyloleanolic acid overcomes Cks1b-induced chemoresistance in lung cancer by inhibiting Hsp90 and MEK pathways.
Topics: Adult; Aged; Animals; Antineoplastic Agents; Benzodioxoles; Carcinoma, Non-Small-Cell Lung; CDC2-CDC28 Kinases; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; Follow-Up Studies; HSP90 Heat-Shock Proteins; Humans; Lung Neoplasms; Male; MAP Kinase Kinase Kinases; MAP Kinase Signaling System; Mice; Mice, Nude; Middle Aged; Oleanolic Acid; Purines; Retrospective Studies; Tumor Burden; Tumor Cells, Cultured | 2017 |